Advanced Biomed (ADVB) Other Non-Current Liabilities (2025)
Advanced Biomed's (ADVB) quarterly Other Non-Current Liabilities came in at $114065.0 in Q4 2025, down 40.27% quarter-over-quarter from $190959.0 in Q3 2025.
Advanced Biomed (ADVB) Other Non-Current Liabilities (2025) Analysis & Trends
Advanced Biomed has disclosed Other Non-Current Liabilities across 1 years of filings, most recently posting $114065.0 for Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $114065.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $114065.0 (changed N/A YoY), and the FY2025 annual result was $69975.0, changed N/A from the prior year.
- Other Non-Current Liabilities came in at $114065.0 for Q4 2025 at Advanced Biomed, down from $190959.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $190959.0 in Q3 2025 to a low of $69975.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Advanced Biomed | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 114,065.00 |
| Sep 30, 2025 | 190,959.00 |
| Jun 30, 2025 | 69,975.00 |